Restriction Landmark Genomic Scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations

Dominic J Smiraglia,Ramakrishnan Kazhiyur-Mannar,Christopher C Oakes,Yue-Zhong Wu,Ping Liang,Tahmina Ansari,Jian Su,Laura J Rush,Laura T Smith,Li Yu,Chunhui Liu,Zunyan Dai,Shih-Shih Chen,Shu-Huei Wang,Joseph Costello,Ilya Ioshikhes,David W Dawson,Jason S Hong,Michael A Teitell,Angela Szafranek,Marta Camoriano,Fei Song,Rosemary Elliott,William Held,Jacquetta M Trasler,Christoph Plass,Rephael Wenger

DOI: https://doi.org/10.1186/1471-2164-8-446

IF: 4.547

2007-01-01

BMC Genomics

Abstract:Background Restriction landmark genomic scanning (RLGS) is one of the most successfully applied methods for the identification of aberrant CpG island hypermethylation in cancer, as well as the identification of tissue specific methylation of CpG islands. However, a limitation to the utility of this method has been the ability to assign specific genomic sequences to RLGS spots, a process commonly referred to as "RLGS spot cloning." Results We report the development of a virtual RLGS method (vRLGS) that allows for RLGS spot identification in any sequenced genome and with any enzyme combination. We report significant improvements in predicting DNA fragment migration patterns by incorporating sequence information into the migration models, and demonstrate a median Euclidian distance between actual and predicted spot migration of 0.18 centimeters for the most complex human RLGS pattern. We report the confirmed identification of 795 human and 530 mouse RLGS spots for the most commonly used enzyme combinations. We also developed a method to filter the virtual spots to reduce the number of extra spots seen on a virtual profile for both the mouse and human genomes. We demonstrate use of this filter to simplify spot cloning and to assist in the identification of spots exhibiting tissue-specific methylation. Conclusion The new vRLGS system reported here is highly robust for the identification of novel RLGS spots. The migration models developed are not specific to the genome being studied or the enzyme combination being used, making this tool broadly applicable. The identification of hundreds of mouse and human RLGS spot loci confirms the strong bias of RLGS studies to focus on CpG islands and provides a valuable resource to rapidly study their methylation.